International Journal of Alzheimer's Disease (Jan 2021)

Validation of AD8-Philippines (AD8-P): A Brief Informant-Based Questionnaire for Dementia Screening in the Philippines

  • Jacqueline C. Dominguez,
  • Ma. Fe P. de Guzman,
  • Ma. Lourdes C. Joson,
  • Krizelle Fowler,
  • Boots P. Natividad,
  • Precy S. Cruz,
  • Jose Leo Jiloca,
  • Primitivo B. Mactal,
  • Jayvee Dyne Dominguez,
  • Jeffrey Domingo,
  • Jhozel Kim Dominguez-Awao,
  • Macario Reandelar,
  • Jem R. Javier,
  • ThienKieuThi Phung,
  • John C. Morris,
  • James E. Galvin

DOI
https://doi.org/10.1155/2021/7750235
Journal volume & issue
Vol. 2021

Abstract

Read online

Aim. This study was aimed at validating the Filipino version of AD8 (AD8-P). Methods. Community-dwelling Filipino older persons aged ≥60 years, together with their informants, participated in this study. Psychologists independently interviewed the informants with AD8-P and administered the Filipino-validated Mini-Mental State Examination (MMSE-P) and Montreal Cognitive Assessment (MoCA-P) to the older persons. Neurologists and geriatrician conducted physical and neurological examination and Clinical Dementia Rating™ (CDR™) to determine cognitive diagnosis and were blinded with the results of AD8-P. Dementia was diagnosed based on DSM-IV-TR criteria. AD8-P discriminatory ability to screen for dementia was evaluated according to DSM-IV-TR diagnostic criteria for dementia. Results. A total of 366 community-dwelling Filipino older persons aged ≥60 years, 213 with normal cognition and 153 with dementia, and their informants were included in this study. Majority (90%) were at the mildest stage of dementia. Area under the receiver-operating-characteristic curve (AUROC) for AD8-P was 0.94 (95% CI 0.92 to 0.96), demonstrating excellent overall predictive power to screen for dementia. The optimal AD8-P cut-off score with best balance sensitivity (91.5%) and specificity (77.9%) was ≥3. Conclusion. AD8-P demonstrated good psychometric properties to screen for dementia, even at the earliest stage of cognitive decline.